Quoin Pharmaceuticals Ltd. ADR buy bundfuture
Zusammenfassung
Diese Einschätzung wurde am 05.02.23 mit einem Endkurs von 2,14 € beendet. Die Einschätzung zu Quoin Pharmaceuticals Ltd. ADR enttäuschte mit einer Rendite von -23,02 %. bundfuture hat 50% Zuversicht bei dieser EinschätzungQuoin Pharmaceuticals (Symbol QNRX) (WKN A3DMEZ) is a publicly traded pharmaceutical company that specializes in developing and commercializing innovative therapeutics for a diverse range of medical conditions. Its skilled team of researchers and industry experts work tirelessly to identify and harness breakthrough technologies that can enhance patient outcomes, improve the overall healthcare landscape, and create sustainable shareholder value. Focused on addressing unmet medical needs and utilizing its unique expertise, Quoin Pharmaceuticals is committed to bringing transformative, life-changing medication to market. With its shares trading on the stock exchange, investors have the opportunity to support the cutting-edge research that drives the company's robust pipeline of promising treatments.
Rendite ohne Dividenden (%)
| Name | 1W | 1M | 1J |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. ADR | - | - | - |
| iShares Core DAX® | 1,80 % | -0,75 % | 13,17 % |
| iShares Nasdaq 100 | -0,18 % | -3,41 % | 39,98 % |
| iShares Nikkei 225® | 0,41 % | -7,38 % | 18,78 % |
| iShares S&P 500 | 0,66 % | -1,94 % | 28,14 % |
Kommentare von bundfuture zu dieser Einschätzung
In der Diskussion Quoin Pharmaceuticals Ltd. ADR diskutieren